Evidence from the Diabetes Control and Complications Trial (DCCT) and its Epidemiology of Diabetes Interventions and Complications (EDIC) study underscores the efficacy of intensive insulin therapy in reducing the risk of CVD in T1DM patients [12]. This evidence concerns the gene INS and diabetes mellitus.